Attenuation of both apoptotic and necrotic actions of cadmium by Bcl-2. by Ishido, Masami et al.
The bcl-2 gene was originally identified
through studies of the t(14:18) chromosomal
translocation associated with human follicular
B-cell lymphoma (1–3). This translocation
juxtaposes the bcl-2 gene to the immunoglob-
ulin heavy-chain gene locus, resulting in
deregulation of bcl-2 gene expression. By
analogy with the translocated c-myc onco-
gene in other tumors, bcl-2 is a candidate
oncogene, but it has not been proven that
bcl-2 protein is itself oncogenic. To explore
the function of bcl-2 proteins, two experi-
ments were carried out (4–7). In transfection
experiments, Vaux et al. (4) showed that
constitutive, high-level expression of bcl-2
protein prolonged cell survival rather acceler-
ating the rate of cell proliferation, and bcl-2
thereby protected many cell types from
apoptosis induced by exposure to a wide
variety of adverse conditions and stimuli.
Another approach was gene targeting in
embryonic stem cells (5–7). Mice with a tar-
geted disruption of the bcl-2 gene display
fulminant lymphoid apoptosis, polycystic
kidneys, and hypopigmented hair (5–7). The
characterization of kidneys of bcl-2–deﬁcient
mice has shown that bcl-2 plays a physio-
logic role in renal organogenesis (8). We
therefore examined whether endogenous
bcl-2 is involved in cadmium-induced renal
apoptosis.
Cadmium is an environmental pollutant
that exerts its toxicity mainly on the kidneys.
The development of cadmium-induced renal
lesions is characterized by proteinuria and
excessive urinary excretion of other substances
such as enzymes, amino acids, and glucose
(9). Recently, it has been shown that the
mode of renal cell death induced by cadmium
is apoptotic (10–15). However, the molecular
transduction pathway of cadmium-induced
apoptosis is unknown. 
Because DNA fragmentation and chro-
matin condensation are deﬁned as common
features of apoptosis, it has been thought to
be a common pathway for apoptotic signal
transduction (16). Further, the targets of the
protective action of bcl-2 should be the mole-
cules that are involved in the putative com-
mon pathway of apoptosis, since bcl-2 can
abrogate the apoptotic cell death induced by a
number of reagents (16). We therefore inves-
tigated the molecular mechanism of metal-
induced apoptosis by examining whether
cadmium exerts effects on the bcl-2 family.
We found that cadmium induced endoge-
nous bcl-2 in porcine kidney LLC-PK1 cells
and rat thymocytes and that overexpression of
bcl-2 impaired both the apoptotic and
necrotic actions of the metal.
Materials and Methods
Porcine renal LLC-PK1 cells were obtained
from the American Type Culture Collection
(CRL1392; Rockville, MD, USA). Cell 
culture media and RNase A were from
Sigma Chemical Corp.(St. Louis, MO).
[α-32P]dCTP (3,000 Ci/mmol) and the
Enhanced Chemiluminescence (ECL)
Western Blotting Detection Kit were from
Amersham Pharmacia Biotech (Uppsala,
Sweden). The c-myc cDNA probe corre-
sponding to human exon 2 was from Takara
(Kyoto, Japan). Mouse bad expression vectors
that were expressed as a glutathione-S-trans-
ferase fusion protein under the control of the
EF-1 alpha promoter were from New
England BioLabs Inc. (Beverly, MA, USA).
The human Bcl-2 cDNA/pUC-CAGGS
expression vector was a gift from Y.
Tsujimoto (University of Osaka, Osaka,
Japan). pRcCMV and pcDNA 3.1/Zeo were
from Invitrogen (Carlsbad, CA, USA). The
mouse monoclonal antibody to human metal-
lothionein was from ZYMED Laboratories,
Inc. (San Francisco, CA, USA). The mouse
monoclonal antibody to human c-Myc, the
rabbit polyclonal antibodies to bax and bcl-
xS/L (catalog no. sc-1041), and the cell lysates
of human B cell lymphoma (BJAB) were
from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA). The mouse monoclonal antibody
to human Bcl-2 was raised against a synthetic
peptide corresponding to amino acids 41–54
of the human Bcl-2 protein. The rabbit poly-
clonal antibody to bad was from New
England BioLabs. Protease inhibitors were
from Peptide Institute Inc. (Osaka, Japan).
Cell culture and transfection. LLC-PK1
cells were grown in Dulbecco’s modified
Eagle’s medium supplemented with 10%
fetal bovine serum, penicillin (100 U/mL),
and streptomycin (100 µg/mL) in a humidi-
ﬁed atmosphere of 95% air and 5% CO2 at
37°C. The cells were subcultured (1:4) two
to three times per week. For the primary thy-
mocytes culture, 9-week-old male Jcl:Wistar
rats were purchased from Clea Japan (Tokyo,
Japan). All animals were treated humanely
according to the guidelines of the National
Institute for Environmental Studies, Japan.
Animals were maintained in stainless-steel
cages at 22°C under a 12 hr light/12 hr dark
cycle and fed standard laboratory feed (MF
diet; Oriental Yeast Co., Tokyo, Japan) and
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Articles
We examined the effects of cadmium on the bcl-2 family of proteins—bcl-2, bax, bad, and
bcl-xS/L—in cadmium-induced cytotoxicity. Addition of 10 µM cadmium to cultured porcine
kidney LLC-PK1 cells caused apoptosis. Western blot analyses revealed that cadmium markedly
increased endogenous bcl-2 protein (to 3–4 times the level in wild-type cells) earlier than metal-
lothionein induction, but that the metal did not enhance the induction of bax, bad, or bcl-xS pro-
teins. Cadmium also induced the transcript of bcl-2, with the amount of bcl-2 reaching a
maximum at 1–2 hr of exposure; this increase occurred earlier than cadmium-induced increase in
the protooncogene such as c-myc. A cadmium-induced increase in endogenous bcl-2 protein was
also seen in rat primary thymocytes. Overexpression of the bcl-2 protein by gene transfection pre-
vented cadmium-induced apoptosis. Following the detection of apoptosis, lactate dehydrogenase
release in the culture medium (a marker of necrosis) was observed, and this release was also inhib-
ited by overexpression of bcl-2. Electron microscopic observations also supported the fact that
cadmium induced apoptotic chromatin condensation at an early stage of exposure, followed by
necrotic features of the cells, both of which were also inhibited by overexpression of bcl-2 pro-
teins. Thus, our data demonstrated that both apoptotic and necrotic actions of cadmium were
attenuated by bcl-2. Key words: apoptosis, bcl-2 family, cadmium cytotoxicity, necrosis. Environ
Health Perspect 110:37–42 (2002). [Online 15 December 2001]
http://ehpnet1.niehs.nih.gov/docs/2002/110p37-42ishido/abstract.htmldistilled water ad libitum. Rat thymuses were
removed from four individuals and were gen-
tly teased through a stainless-steel mesh in
RPMI 1640 (Life Technologies, Rockville,
MD, USA). The thymocytes were then
washed with fresh, serum-free RPMI 1640
medium by centrifuge. The cell viability of
the thymocytes thus obtained was deter-
mined to be 90–95% by the trypan blue
exclusion method. 
For transfection, the human Bcl-2
cDNA/pUC-CAGGS (2 µg) was co-trans-
fected with pRcCMV (1 µg) into the
LLC-PK1 cells, which had been plated at 1.2
× 106 cells/10-cm tissue culture dish 16 hr
before transfection, by the calcium phos-
phate/glycerol shock method (17). After 24
hr, cells were trypsinized and split at a ratio
of 1:15 and grown in medium supplemented
with 800 µg/mL G418 (Life Technologies).
A single clone of G418-resistant transfec-
tants was isolated with a penicillin cup and
expanded into a 10-cm tissue culture dish.
To identify the clones expressing human
Bcl-2 proteins, cell homogenates were
prepared according to the method described
previously (18). Positive cell lines synthe-
sized a protein of approximately 26 kDa
when analyzed by SDS-polyacrylamide gel
electrophoresis, which corresponds to the
predicted size of the bcl-2 protein. The sta-
ble cell lines were subcultured twice weekly
and maintained in medium supplemented
with 800 µg/mL G418. Several clones that
expressed bcl-2 proteins at different expres-
sion levels were propagated. Among them,
clone TI 14 sowed the highest expression of
bcl-2 protein, approximately 20-fold higher
than that for the wild type cells. 
The bad expression vector (2 µg) was co-
transfected with pcDNA3.1/Zeo (1 µg) into
the clone TI 14 as above. The cells were
grown in Zeocin (1 mg/mL; Invitrogen). The
nonclonal cells of Zeocin-resistant transfec-
tants served as a positive control in the
Western blot analyses of bad proteins (Figure
1B, lane 9).
DNA fragmentation analysis. DNA frag-
mentation analysis was carried out as
described previously (19). The LLC-PK1 cells
were subcultured at 70% confluency and
maintained in serum-free medium for 16 hr
before the addition of cadmium. Treated
cells (4–10 × 106) were then washed twice
with phosphate-buffered saline (PBS) and
lysed in 5 mM Tris buffer, pH 7.4, contain-
ing 0.5% Triton X-100 and 20 mM EDTA
at 4°C for 20 min. After centrifugation at
28,000 × g for 20 min, DNA fragments were
extracted with phenol-chloroform and pre-
cipitated in ethanol. These samples were then
treated with 20 µg/mL RNase A and elec-
trophoresed on a 1.2% agarose gel.
Northern blot analysis. Total cellular
RNA was isolated by means of single-step
guanidium thiocyanate-phenol-chloroform
extraction (20). The RNA was denatured
with 1 M glyoxal and 50% dimethyl sulfox-
ide, electrophoresed on an agarose gel, and
transferred to a Hybond-N nylon membrane
(Amersham Pharmacia Biotech). Filters were
hybridized with the 32P-labeled c-myc cDNA
or bcl-2 cDNA probes at 60°C for 16 hr,
then washed twice with 2 × SSC (1 × SSC =
0.15 M NaCl, 0.015 M sodium citrate (pH
7.0) at room temperature for 5 min, twice
with 2 × SSC plus 1% SDS at 60°C for 30
min, and twice with 0.1 × SSC at room tem-
perature for 30 min. The filters were then
exposed to an imaging plate (Fuji Film,
Tokyo, Japan), and the plate was analyzed
with a Fuji Film Bioimage Analyzer (Fujix
BAS 2000; Fuji Film).
Cell lysates and Western blot analysis.
Cells were collected by centrifuge at 600 × g
for 5 min and homogenized in 20 mM
Hepes, pH 7.8, containing 1.5 mM MgCl2,
10 mM KCl, 0.5 mM dithiothreitol, and pro-
tease inhibitors [0.5 mM phenylmethylsul-
fonyl ﬂuoride (Wako Co., Osaka, Japan), 5
µg/ml pepstatin (Peptide Institute Inc.,
Osaka, Japan), and 5 µg/ml leupeptin
(Peptide Institute Inc.)]. The homogenates
were kept in ice for 10 min and used for total
cell lysates. For cell fractionation, cytosolic
and nuclear factions were prepared as
described (21). Total cell lysates were cen-
trifuged at 2,000 × g for 10 min and the
supernatants were used as cytosolic fractions.
The pellets were resuspended in 20 mM
Hepes, pH 7.8, containing 0.42 mM NaCl,
1.5 mM MgCl2, 0.2 mM EDTA, 0.2 mM
dithiothreitol, 25% glycerol, and the above-
mentioned protease inhibitors at 4°C for 30
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Figure 1. Western blot analyses of the effects of cadmium or zinc on the bcl-2 family proteins bax (A), bad
(B), bcl-xS/L (C), and bcl-2 (D), and on c-myc (E) and metallothionein (F). LLC-PK1 cells were starved in
serum-free medium 16 hr before the addition of 10 µM cadmium or 50 µM zinc for the indicated periods.
Twenty micrograms of each protein was subjected to an SDS-polyacrylamide gel electrophoresis and
immunoblotted with antibodies against bax (A), bad (B), bcl-xS/L (C), bcl-2 (D), c-myc (E), or metallothionein
(F). B, lane 9, shows the results for a cell lysate from clone TI 14 cells that were transfected with mouse bad
cDNA and C, lanes 1 and 11, show the results for cell lysates of BJAB (10 µg of proteins) for a positive con-
trol of immunoreaction with anti-bcl-xS/L antibodies that can recognize both bcl-xS and bcl-xL proteins.
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Figure 2. Induction by cadmium of transcripts of
bcl-2 (A) and c-myc (B) in cadmium-treated
LLC-PK1 cells. LLC-PK1 cells were starved in
serum-free medium 16 hr before the addition of 10
µM cadmium for the indicated periods. Total RNA
(10 µg) was isolated and electrophoresed on an
agarose gel, then probed with [32P] bcl-2 (A). After
stripping, the sheet was rehybridized with [32P]c-
myc (B). C is a UV photograph of an ethidium bro-
mide-stained gel and shows the amount of
loading as judged by the intensity of the 18s and
28s rRNA bands. 
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Cmin. Then the samples were centrifuged at
25,000 × g for 20 min at 4°C and the clear
supernatants were used as nuclear fractions.
Protein concentrations were measured with a
bicinchoninic acid kit (Pierce Chemical Co.,
Rockford, IL, USA) using bovine serum
albumin as a standard. Proteins (5–20 µg)
were subjected to 7.5 or 15% polyacry-
lamide gels containing 0.1% SDS under
reducing conditions (22). Proteins in an
SDS gel were electrophoretically transferred
at 2 mA/cm2 for 20 min onto Immobilon
membranes (Millipore Co., Osaka, Japan) in
25 mM Tris, 192 mM glycine, and 20%
methanol with an Atto semidry horizontal
electrophoretic transfer unit (Atto, Tokyo,
Japan). The membrane was blocked with
8% casein in PBS containing 0.1% Tween
20 at room temperature for 3 hr. The trans-
ferred membrane was then incubated with
monoclonal antibodies against bcl-2, c-Myc,
or metallothionein or polyclonal antibodies
against bax, bcl-xS/L, or bad at concentra-
tion of a 1–2 µg/mL in PBS containing
0.1% Tween 20 and 5% bovine serum albu-
min overnight at 4°C. After incubation with
primary antibodies, the sheets were washed
three times for 5 min each with PBS con-
taining 0.1% Tween 20, and the antibodies
were detected with horseradish peroxidase-
conjugated secondary IgG using an
Enhanced Chemiluminescence (ECL)
Western Blotting Detection Kit according to
the manufacturer’s instructions (Amersham
Pharmacia Biotech). Gels were calibrated
with prestained molecular markers (Bio-Rad,
Hercules, CA, USA). 
Lactate dehydrogenase activity. The
enzyme released into the cultured medium
was assayed using Wako assay kits (Wako).
Total lactate dehydrogenase (LDH) activity
was determined in cells that had been treated
with 0.2% Tween-20 for 24 hr.
Fluorescence microscopy. Cells were
stained with 1 µg/mL propidium iodide
(Wako) for 20 min on ice and analyzed
under a fluorescence microscope (E400;
Nikon, Tokyo, Japan) with excitation at 535
nm, as described (23).
Electron microscopy. Cells were trypsinized
and fixed with 2.5% sodium phosphate-
buffered glutaraldehyde (pH 7.4) at room
temperature for 30 min. After washing with
PBS, the samples were treated with 10%
bovine albumin in PBS. Then the samples
were sedimented at 2,000 × g for 5 min and
further ﬁxed with 2.5% sodium phosphate-
buffered glutaraldehyde (pH 7.4) at 4°C
overnight. The samples were postﬁxed for 1
hr with 1% veronal acetate-buffered osmium
tetroxide. Ultrathin sections were stained in
ethanolic uranyl acetate and lead citrate and
examined by electron microscopy (JEM-200
FX; JEOL, Tokyo Japan).
Results
To examine the effects of cadmium on bcl-2
family protein expression, comparing effects
with those of zinc, 10 µM cadmium or 50
µM zinc was added to cultured LLC-PK1 cells
for the indicated periods and the treated cells
were harvested and homogenized. The total
cell lysates (20 µg of proteins) were analyzed
by Western blotting for bax, bad, bcl-xS/L,
and bcl-2 proteins (Figure 1A–D). The
nuclear fractions (20 µg of proteins) were ana-
lyzed for the presence of c-Myc proteins
(Figure 1E). The cytoplasmic fractions (20 µg
of proteins) were analyzed for metallothionein
(Figure 1F). In our previous study (11), ethid-
ium bromide staining revealed DNA frag-
mentation as early as 7 hr after exposure to 10
µM cadmium. Among the bcl-2 family pro-
teins tested in the study, Figure 1 shows that
the levels of bcl-2 protein were most markedly
increased by cadmium, with the level of bcl-2
after exposure to cadmium being 3- to 4-fold
greater than the basal level (Figure 1D, lanes
1, 3, and 4). The induction of the bcl-2 pro-
tein by cadmium occurred much earlier than
the induction of metallothionein (Figure 1F).
Bax, bad, and bcl-xS proteins were not
induced by cadmium, suggesting that they
may not be death mediators of cadmium-
induced apoptosis (Figure 1A–C). Using
cytosolic fractions, the induction of bcl-2 pro-
teins by cadmium was also observed with the
same extent as that of total cell lysates, and
the levels of bcl-xL was enhanced by cad-
mium, but to a lesser degree (data not
shown). c-Myc protein levels were unchanged
at least up to 24 hr (Figure 1E). In contrast,
zinc plays an antiapoptotic role against the
apoptotic action of cadmium (11,18). Among
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Figure 3. Induction by cadmium of DNA fragmentation (A) and bcl-2 proteins (B) in rat primary thymocytes.
Rat thymocytes (1 × 107) were treated with 10 µM cadmium for 7 hr to analyze DNA fragmentation (A) and
for the indicated periods for Western blot analyses (B) as described in “Materials and Methods.” Twenty
micrograms of each protein from the cytosolic fractions was subjected to an SDS-polyacrylamide gel elec-
trophoresis and immunoblotted with monoclonal antibodies against bcl-2 (B). 
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assessed as described in “Materials and Methods.” Size markers are shown in lane 1.
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17.8the bcl-2 family proteins tested, bcl-2 and bcl-
xL proteins were markedly increased by zinc
(Figure 1C, D), and Bax protein was some-
what increased (Figure 1A). This suggested
that not only bcl-2 protein, but also bcl-xL
protein, is involved in zinc-regulated cell sur-
vival (18). Neither cadmium nor zinc induced
bad protein (Figure 1B). Thus, cadmium
caused apoptosis with concomitant induction
of endogenous antiapoptotic proteins bcl-2 in
an early stage of the cytotoxicity.
We next examined the effects of cadmium
on the transcript level of bcl-2 by Northern
blotting, comparing with that of c-myc as the
immediate early gene. Treatment of renal cells
with 10 µM cadmium induced a transient
increase in bcl-2 transcript levels at 1–2 hr
after exposure to the metals (Figure 2A). This
increase occurred before that of c-myc tran-
script, which peaked at 3 hr (Figure 2B)
(24,25). 
Since cadmium also exerts effects on the
functions of the immune system (26,27), we
investigated the apoptotic effects of cadmium
on rat thymocytes to explore whether the
induction of bcl-2 by cadmium seen in
LLC-PK1 cells was general. As shown in
Figure 3A, DNA fragments formed 7 hr after
addition of cadmium (10 µM) to rat primary
thymocytes (1 × 107). Figure 3B shows that
cadmium also increased the level of bcl-2
protein in rat primary thymocytes.
To examine the role of the induction of
endogenous bcl-2 by cadmium, cell lines that
overexpressed bcl-2 proteins were established.
Human Bcl-2 cDNA was transfected into the
cultured LLC-PK1 cells. Several clones that
expressed bcl-2 proteins at different expression
levels were propagated. Figure 4A shows the
expression levels of the bcl-2 proteins of ﬁve
clones, TI 19, TI 11, TI 15, TI 17, and TI 14.
TI 17 and TI 14 expressed the bcl-2 proteins
in amounts 7–8- and 20-fold higher than those
of wild-type cells, respectively. In correlation
with the level of bcl-2 proteins expressed, apop-
tosis induced by cadmium (10 µM for 7 hr)
was inhibitable (Figure 4B). An amount of bcl-
2 approximately 7–8 times the amount present
in wild-type cells was sufﬁcient to antagonize
the apoptotic action of the metal (clone TI 17).
Finally, we examined the effect of overex-
pression of the bcl-2 protein on LDH release,
since cadmium also exerts necrotic action (9).
In wild-type LLC-PK1 cells, LDH activity
was not detected in the medium at up to 7 hr
after exposure to 10 µM cadmium, where
DNA fragmentation induced by the metal
had already been observed (Figure 5A). After
24 hr, 75–100% of total LDH was detected
in the medium. However, overexpression of
human bcl-2 dramatically suppressed the
release of LDH into the medium (Figure
5A), indicating that bcl-2 also prevents the
necrotic action of the metal.
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Figure 5. (A) Overexpression of Bcl-2 proteins prevents LDH release caused by cadmium. Control LLC-PK1
cells and LLC-PK1 derivatives (TI 14) expressing human Bcl-2 were cultured in 24-well plates and exposed
to 10 µM cadmium for the indicated periods. The activity of LDH released into the culture medium (1 mL)
was measured. Results were represented as a percentage of the total LDH activity, which was obtained
by treatment of the cells with 0.2% Tween 20 for 24 hr (mean ± SE). (B) Propidium iodide-staining analyses
of the mode of cadmium-induced cell death of wild-type LLC-PK1 (a-d) and in clone TI 14 (e-h) cells. Cells
were treated with 10 µM cadmium for the indicated periods. Then the cells were stained with 1 µg/mL
propidium iodide for 20 min on ice and analyzed under a ﬂuorescence microscope. Original magniﬁcation,
× 200. (C) Ultrastructural analyses of cadmium-treated wild-type LLC-PK1 (a-c) and clone TI 14 (d-f) cells.
Cells were treated with 10 µM cadmium for 0 hr (a and d), 9 hr (b and e), and 26 hr (c and f). The cells were
then fixed with 2.5% glutaraldehyde and postfixed with 1% veronal acetate-buffered osmium tetroxide.
Ultrathin sections were stained in ethanolic uranyl acetate and lead citrate and examined by electron
microscopy. Original magniﬁcation: a, × 2,000; b, × 3,000; c, × 2,500; d, × 3,000; e, × 2,000; f, × 2,500.
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CThese results were also conﬁrmed by pro-
pidium iodide-staining experiments. We pre-
viously showed that cadmium induced
chromatin condensation in rat kidneys (12)
and cultured kidney cells (25,28), as detected
by staining the nuclei of Triton X 100-per-
meabilized specimens with Hoechst 33258.
Propidium iodide stains the nuclei of termi-
nal apoptotic cells and necrotic cells with dis-
rupted membrane integrity (29). Exposure to
10 µM cadmium for 5 hr gave propidium-
stained condensed nuclei in wild-type
LLC-PK1 cells (terminal apoptotic phase),
but not in TI 14 clone cells, indicating that
overexpression of bcl-2 completely inhibited
cadmium-induced apoptosis (Figure 5B).
Further exposure of the cells to cadmium (17
hr) gave propidium iodide-staining both in
wild-type LLC-PK1 cells and in clone TI 14
cells (necrotic phase); the population of pro-
pidium iodide-stained cells in clone TI 14
was much less than that in wild-type cells,
indicating that bcl-2 partially inhibited the
necrotic action of cadmium (Figure 5B).
Figure 5C shows the electron micrograph
of morphologic features of wild-type LLC-
PK1 cells or clone TI 14 cells. Chromatin
condensation was induced by cadmium in
wild-type cells (Figure 5C), but not in clone
TI 14 cells, indicating that overexpression of
bcl-2 proteins prevented cadmium-induced
condensation of chromatin in the cells. Clear
vacuoles were numerous in the altering cyto-
plasm (Figure 5C). The chromatin was
degradated by cadmium in wild-type cells
with some large cytosolic vacuoles, indicating
the late stage of necrosis. In contrast, chro-
matin degradation was not seen in clone T14
cells but abundant lysosomes were seen.
Discussion
Exposure of cells to cadmium evokes a num-
ber of cellular responses to protect the cell
from the metal-induced cytotoxicity (30).
One primary protective molecule is glu-
tathione. Intracellular cadmium ions which
escape sulfhydryl reaction with glutathione
exert numerous cellular responses, including
the induction of protooncogenes and heat
shock proteins. Ultimately, free cadmium
ions are sequestered by chemical reaction
with metallothionein, which is induced at a
later phase of cadmium cytotoxicity. 
Recent discovery of the apoptogenic
nature of cadmium has allowed us to exam-
ine the effects of cadmium on such bcl-2
family proteins as bax, bad, bcl-xS/L, and
bcl-2 in porcine kidney LLC-PK1 cells. In
this study, we compared the rates of induc-
tion of each of these proteins by cadmium
and found the most marked increase in the
protein bcl-2, which cadmium increased to
three to four times the level in wild-type
cells. Cadmium was also shown to induce
bcl-2 in rat primary thymocytes. Because
death molecules such as bax, bad, and bcl-xS
were not induced by cadmium, they might
not be involved in the apoptotic mechanism
of cadmium. The level of induction of
endogenous bcl-2 proteins was not sufﬁcient
to completely suppress apoptosis induced by
cadmium (10 µM for 7 hr). The physiologic
role of induction of endogenous bcl-2 by
cadmium was deduced from the results
obtained from the cell line (clone TI 14)
that overexpressed bcl-2 protein at a rate
about 20-fold higher than that of the control
cells; the TI 14 clone could completely
antagonize the apoptotic action of the metal
(Figure 4B). 
Furthermore, overexpression of bcl-2
inhibited cadmium-induced LDH release
into the medium, which is associated with
necrosis. This suggests that bcl-2 can prevent
not only apoptotic action but also necrotic
action of the metal. This result was also sup-
ported by ultrastructural analyses of mor-
phologic features of the cells exposed to
cadmium. It remains unknown if the apop-
totic signaling pathway might be coupled to
a necrotic one, both of which are evoked by
cadmium, and if bcl-2 functions at the step
of the crossover of both pathways.
Bcl-2 is thought to be a common media-
tor for prevention of programmed cell death
because bcl-2 can suppress apoptotic cell
death induced by a variety of physiologic and
nonphysiologic reagents (16,31). Therefore,
cadmium-induced apoptotic signals might
also be transduced via the putative common
pathway of apoptosis. 
The induction of bcl-2 proteins occurred
much earlier than the induction of metalloth-
ionein. Metallothionein is a well-known
biochelator for the metals that is inducible at
the late stage of metal cytotoxicity. Because
metallothionein contains a high proportion
of cysteine residues (30%), metal detoxiﬁca-
tion by metallothionein is based on the
chemical reaction of divalent metals with cys-
teine residues of the protein. However, bcl-2
contains only a few cysteine residues, and
they are not conserved among all species so
far sequenced (32). 
Thus, although the molecular mecha-
nism of the regulation of detoxification by
bcl-2 remains unclear, our data suggest that
bcl-2 protein may play an inducible cytopro-
tective role against cadmium toxicity. 
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